KING & SPALDING LLP

Lobbying for KANEKA PHARMA AMERICA, LLC · Distributor of life science systems

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · $40,000.00 income · posted Apr 17, 2025

Bills named in this filing 1

Lobbying activity 1

Medicare/Medicaid

Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 8999 (118th Cong.).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.